Enanta Pharmaceuticals ENTA Earnings Call Transcripts

NASDAQ ENTA
$11.60 +0.38 (+3.39%)
At close: Nov 11, 2026 · 4:00 PM EST
11 earnings calls on file for Enanta Pharmaceuticals, from Q1 2020 to Q3 2022. Each transcript opens in a new tab.
Latest earnings call

Enanta Pharmaceuticals Q3 2022 Earnings Call

Aug 8, 2022 6,374 words · 28 min read
  • Jay LulyPresident and Chief Executive Officer
  • Paul MellettChief Financial Officer
  • Jennifer VieraInvestor Relations
  • Tara KiefferSenior Vice President, New Product Strategy and Development
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Enanta Pharmaceuticals Earnings Call Transcripts

Calls11
LatestAug 8, 2022
SinceQ1 2020

Fiscal 2022

Fiscal 2021

Fiscal 2020

All 11 Enanta Pharmaceuticals transcripts Register to get access to Enanta Pharmaceuticals’s earnings call transcripts.